Joshua Sopp is a Senior Scientist at RevoNA Bio since November 2023, with previous experience as a Senior Scientist at Novacyt Group from May 2021 to November 2023, where responsibilities included leading the design and development of diagnostic products. Prior to that, Joshua served as a Technical Scientist, focusing on the development of qPCR diagnostic products. As a Research Fellow at the University of Southampton from October 2019 to May 2021, Joshua directed post-doctoral research that expanded the use of multimeric antibody technology. Earlier experience includes a role as a Research Associate at Ipsen Bioinnovation Ltd, where contributions were made to the development of a therapeutic engineered botulinum neurotoxin. Joshua holds a PhD in Cancer Sciences and an MSci in Biological and Biomedical Sciences from the University of Southampton.
This person is not in the org chart
This person is not in any teams
This person is not in any offices